Binge Eating Disorder Market Analysis- Application, Type, Voltage, End-User, Category, Global Trends and Forecast To 2022

ReportBazzar has released its latest research-based report entitled ‘Binge Eating Disorder’ market.

This report provides a holistic approach to the market growth with a detailed and precise analysis of the overall competitive scenario of the Binge Eating Disorder market. The report also provides a detailed analysis of key trends and latest technologies, playing a prominent role in the Binge Eating Disorder market growth. It takes into account aspects such as drivers, restraints, challenges, and opportunities that impact the market and presents statistical and analytical account on it. This research report features a comprehensive discussion about the current scenario to estimate trends and prospects of the Binge Eating Disorder market soon. The overall market provides detailed dynamic and statistical insights pertaining to the market at both regional and global level.

Get Free Sample Copy of this Report @:
http://www.reportbazzar.com/request-sample/?pid=988964&ptitle=Binge+Eating+Disorder+%26%238211%3B+Pipeline+Review%2C+H1+2017&req=Sample

Healthcare industry: Is it growing or stagnant?

The healthcare industry or health economy is the aggregation or integration of industries within the economic system that provides goods & services to treat the patients with preventive, curative, palliative and rehabilitative care. Healthcare industry has been grabbing attention in the recent past and is expected to continue a similar trend over the forecast period. Growing number of diseases and increasing concern & awareness about health are the factors contributing to the growth of Binge Eating Disorder industry and in turn healthcare industry and its related industries. Development of newer products coupled with innovation of new technologies, as well as increasing investments in R&D by companies, is further widening the market scope and revenue growth of the total market.

Research Methodology:

Recognizing the rising prevalence of Binge Eating Disorder market, this research report proves to be a primary source of guidance and detailed data on the market at global scale. The report evaluates the present scenario as well as changing trends in the market to project its outlook and prospects. A holistic report covers exhaustive information obtained from reliable industrial sources and through proven research methodologies. The report goes through both secondary and primary survey. The base year taken for the report is 2015 and 2016, and a forecast is done from 2017 to 2025.The data thus obtained is then combined with relevant tables and graphs to support the information revealed.

Browse full report with Table of Content @:
http://www.reportbazzar.com/product/binge-eating-disorder-pipeline-review-h1-2017/
Product & Application Insights:
Various competent analytical tools have been used to offer a comprehensive assessment of the market. The report comprises of each aspect of the global market for Binge Eating Disorder. It starts with the basic information and then advances to the market segmentation based on different criteria such as technology, products, application and regions in general. A detailed analysis is also given on the market penetration and future prospects of the overall industry growth. Each product has its specific applications. There is detailed approach provided for each product and application such has which product has the highest penetration and which application is growing at a significant rate. These factors are complemented by diagrams such as bar graph or pie diagram.

Regional Insights:

Major regions, countries, and sub-segments have been analyzed for providing the better understanding of the market scope worldwide.  The regions taken into consideration are North America, Europe, Asia Pacific, Middle East & Africa and Central & South America. The report studies the market by evaluating the manufacturers, suppliers, and supply chain or value chain management. Favorable regulations, prevalent policies and cost structures are also analyzed. The regional markets for the Binge Eating Disorder market are analyzed by evaluating the pricing of products, logistics, demand, and supply, production capacity, as well as the historical performance of the market in the given region.

Competitive Insights:

The report also provides insights on the competitive landscape of the global Binge Eating Disorder industry with the leading players profiled in the report. Company profiles are purely tentative in nature and we can profile companies according to your interest at free cost. The Binge Eating Disorder market is highly competitive and regulated. The company overview, trends, tactics, merger & acquisitions, business strategies, financial metrics of the major participants operating in the global Binge Eating Disorder market have been reviewed in this study.

Ask for Discount @:
http://www.reportbazzar.com/discount-form/?pid=988964&ptitle=Binge+Eating+Disorder+%26%238211%3B+Pipeline+Review%2C+H1+2017&req=Discount

Some Points Of Table Of Content:

List of Tables
List of Figures
Introduction
Global Markets Direct Report Coverage
Binge Eating Disorder – Overview
Binge Eating Disorder – Therapeutics Development
Pipeline Overview
Pipeline by Companies
Products under Development by Companies
Binge Eating Disorder – Therapeutics Assessment
Assessment by Target
Assessment by Mechanism of Action
Assessment by Route of Administration
Assessment by Molecule Type
Binge Eating Disorder – Companies Involved in Therapeutics Development
Chronos Therapeutics Ltd
F. Hoffmann-La Roche Ltd
Heptares Therapeutics Ltd
Highland Therapeutics Inc
Omeros Corp
Opiant Pharmaceuticals Inc
Shire Plc
Sunovion Pharmaceuticals Inc
Binge Eating Disorder – Drug Profiles
amphetamine MR – Drug Profile
Product Description
Mechanism Of Action
R&D Progress
CTDP-002 – Drug Profile
Product Description
Mechanism Of Action
R&D Progress
dasotraline hydrochloride – Drug Profile
Product Description
Mechanism Of Action
R&D Progress
lisdexamfetamine dimesylate – Drug Profile
Product Description
Mechanism Of Action
R&D Progress
naloxone hydrochloride – Drug Profile
Product Description
Mechanism Of Action
R&D Progress
OMS-527 – Drug Profile
Product Description
Mechanism Of Action
R&D Progress
RO-5256390 – Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Small Molecule to Antagonize Orexin 1 for Central Nervous System Disorders – Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Binge Eating Disorder – Dormant Projects
Binge Eating Disorder – Discontinued Products
Binge Eating Disorder – Product Development Milestones
Featured News & Press Releases
Jan 13, 2017: Sunovion Announces Top-line Results from Studies Evaluating Dasotraline in Adults with Binge Eating Disorder and Attention Deficit Hyperactivity Disorder
Oct 25, 2016: First And Only Medication Approved In Canada For The Treatment Of Binge Eating Disorder
Oct 17, 2016: Shire Announces Update to Vyvanse (lisdexamfetamine dimesylate) U.S. Labeling to Include New Longer-Term Maintenance of Efficacy Data in Adults with Moderate to Severe Binge Eating Disorder
Oct 06, 2016: Study Finds New Approach to Block Binge Eating
Apr 14, 2016: Shire Submits NDA to FDA for New Formulation of Vyvanse (lisdexamfetamine dimesylate) CII as Chewable Tablets
Jan 25, 2016: Sunovion Announces Results from a Study Evaluating the Abuse Potential of Investigational Drug Dasotraline
Jul 22, 2015: Vyvanse (lisdexamfetamine dimesylate) Positive Top-Line Results in Maintenance of Efficacy Study in Adults with Moderate to Severe Binge Eating Disorder
Jun 13, 2015: PTAB Invalidates Lucerne Biosciences’ ‘813 Patent for the Treatment of Binge Eating Disorder with Lisdexamfetamine Dimesylate
May 11, 2015: Shire to Present New Research at American Psychiatric Association Annual Meeting
Jan 30, 2015: Vyvanse (lisdexamfetamine dimesylate) Capsules (CII) Becomes First and Only Treatment Approved by the FDA for Adults with Moderate to Severe Binge Eating Disorder
Sep 15, 2014: Shire Announces FDA Acceptance for Filing with Priority Review of Supplemental New Drug Application (sNDA) for Vyvanse (lisdexamfetamine dimesylate) Capsules (CII) for Adults with Binge Eating Disorder
Nov 05, 2013: Positive Top-line Results Shown for Vyvanse Capsules in Adults with Binge Eating Disorder
May 17, 2013: Shire To Present Scientific Data On Vyvanse At 166th APA Annual Meeting 2013
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer

About us:

Reportbazzar.com is your trusted source for the most inclusive and informative assortment of market research reports designed to empower you with the latest in industry information that translates to time and cost savings for your business. We not only help you give wing to your latent business ideas but also facilitate you in taking the best informed and strategic decisions that guarantee success in your most promising business endeavors. Our intelligence database comprises of vast arrays of strategically analyzed and high-level market research reports that encompass all major industries worldwide. All the specialized research reports available at Reportbazzar.com are tailor-made to suit your every business need, no matter how diverse or demanding it is.

Contact for more details:

Report Bazzar
United States
30 Wall Street, 8th floor,
New York, NY 10005.
US: +1 (212) 389-6363
Email:
sales@reportbazzar.com
Web –
http://www.reportbazzar.com

Designed by CyFocus.com
Powered by CyFocus.net
%d bloggers like this: